financemarket.news

 

 

 

Catenae Innovation focused on commercialising Cov-ID app after positive


Catenae Innovation PLC’s (LON:CTEA) Guy Meyer caught up with Proactive London’s Andrew Scott after announcing its partner Newcastle Premier Health has successfully completed a proof-of-concept pilot trial of the Cov-ID app. Cov-ID is GDPR compliant identity documentation exchange system to record an individual’s coronavirus (COVID-19) test status through a mobile application.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is…

In exchange for publishing services rendered by the Company on behalf of Catenae Innovation PLC named herein, including the promotion by the Company of Catenae Innovation PLC in any Content on the Site, the Company…

FOR OUR FULL DISCLAIMER CLICK HERE



Read More: Catenae Innovation focused on commercialising Cov-ID app after positive

Leave a comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.

Thank you for subscribing.

Something went wrong.